Muscular Atrophy, Spinal

9 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Nervous System Diseases, Neurodegenerative Diseases

Narrower: Bulbo-Spinal Atrophy, X-Linked 2, Spinal Muscular Atrophies of Childhood 4

Treatments and conditions

Muscular Atrophy, Spinal
Treatment and conditionWhere it standsTrials
Apitegromab for spinal muscular atrophies of childhoodPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
GC101 for muscular atrophy, spinalPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
OAV101 for bulbo-spinal atrophy, x-linkedPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Onasemnogene abeparvovec for bulbo-spinal atrophy, x-linkedPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Onasemnogene abeparvovec for muscular atrophy, spinalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Onasemnogene abeparvovec for spinal muscular atrophies of childhoodPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Risdiplam for muscular atrophy, spinalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
SKG0201 Injection for spinal muscular atrophies of childhoodPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Spinal Cord Stimulator (Octopolar Medtronic Vectris Leads) for spinal muscular atrophies of childhoodTrial registered, as of 19 Nov 2026 (not yet checked by a person)2

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.